Y. YILMAZ Et Al. , "Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.," Hepatology (Baltimore, Md.) , vol.49, no.2, 2009
YILMAZ, Y. Et Al. 2009. Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.. Hepatology (Baltimore, Md.) , vol.49, no.2 .
YILMAZ, Y., Ulukaya, E., & Dolar, E., (2009). Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.. Hepatology (Baltimore, Md.) , vol.49, no.2.
YILMAZ, YUSUF, Engin Ulukaya, And MAHMUT ENVER DOLAR. "Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.," Hepatology (Baltimore, Md.) , vol.49, no.2, 2009
YILMAZ, YUSUF Et Al. "Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.." Hepatology (Baltimore, Md.) , vol.49, no.2, 2009
YILMAZ, Y. Ulukaya, E. And Dolar, E. (2009) . "Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.." Hepatology (Baltimore, Md.) , vol.49, no.2.
@article{article, author={YUSUF YILMAZ Et Al. }, title={Serum M30 levels: a potential biomarker of severe liver disease in nonalcoholic fatty liver disease and normal aminotransferase levels.}, journal={Hepatology (Baltimore, Md.)}, year=2009}